Defeng Deng
Overview
Explore the profile of Defeng Deng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
855
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cohen L, Delorme A, Cusimano A, Chakraborty S, Nguyen P, Deng D, et al.
Sci Rep
. 2024 Dec;
14(1):29221.
PMID: 39622875
In this case study, a self-described biofield therapy (BT) practitioner (participant) took part in multiple (n = 60) treatment and control (non-treatment) sessions under double-blind conditions. During the treatment phases,...
2.
Li H, Liu C, Zhu J, Huan X, Xu K, Geng H, et al.
J Colloid Interface Sci
. 2024 Jun;
672:465-476.
PMID: 38852349
Enhancing the flame retardancy of epoxy (EP) resins typically entailed a trade-off with other physical properties. Herein, hyperbranched poly(amidoamine) (HPAA) and phytic acid (PA) were used to functionalize graphene oxide...
3.
Johnson F, Janku F, Gouda M, Tran H, Kawedia J, Schmitz D, et al.
Oncologist
. 2022 Sep;
27(12):1004-e926.
PMID: 36124629
Background: PI3K/mTOR inhibition leads to apoptosis of NOTCH1-mutant head and neck squamous cell carcinoma (HNSCC) cells. We tested the efficacy of the PI3K/mTOR inhibitor bimiralisib in patients with NOTCH1-mutant HNSCC....
4.
Ahmed K, Veeramachaneni R, Deng D, Putluri N, Putluri V, Cardenas M, et al.
J Immunother Cancer
. 2022 Aug;
10(8).
PMID: 36002187
Background: The existence of immunologically 'cold tumors' frequently found across a wide spectrum of tumor types represents a significant challenge for cancer immunotherapy. Cold tumors have poor baseline pan-leukocyte infiltration,...
5.
Wan P, Ongkasuwan J, Martinez J, Sandulache V, Deng D, Jiang J, et al.
Otolaryngol Head Neck Surg
. 2020 Sep;
164(4):751-758.
PMID: 32988279
Objective: To explore biomarkers that are candidates for understanding potential degeneration to malignancy of vocal fold leukoplakia (VFL), with the goal of guiding future diagnostic and treatment recommendations. Data Sources:...
6.
Deng D, Yang S, Wang X
Biosci Rep
. 2020 May;
40(5).
PMID: 32412051
Neuroblastoma (NB) is an extracranial solid tumor in children with complex mechanism. Increasing reports indicated that long non-coding RNA (lncRNA) small nucleolar RNA host gene 16 (SNHG16) account for the...
7.
Huang H, Chen J, Peng L, Yao Y, Deng D, Zhang Y, et al.
Am J Physiol Gastrointest Liver Physiol
. 2018 Nov;
316(1):G179-G186.
PMID: 30431318
Replacement of the exocrine parenchyma by fibrous tissue is a main characteristic of chronic pancreatitis. Understanding the mechanisms of pancreatic fibrogenesis is critical for the development of preventive and therapeutic...
8.
Zhou L, Husted H, Moore T, Lu M, Deng D, Liu Y, et al.
Sci Transl Med
. 2018 Oct;
10(464).
PMID: 30355799
Pancreatic ductal adenocarcinoma (PDAC) has a dismal prognosis, and it is unclear whether its stromal infiltrate contributes to its aggressiveness. Here, we demonstrate that Dickkopf-3 (DKK3) is produced by pancreatic...
9.
Tong Z, Chatterjee D, Deng D, Veeranki O, Mejia A, Ajani J, et al.
Oncotarget
. 2017 Apr;
8(17):28696-28710.
PMID: 28404924
Role of cyclin dependent kinase 9(CDK9) as a potential target in esophageal adenocarcinoma (EAC) is unknown. We investigated CDK9 protein expression in EAC and Barrett's esophagus and role of CDK9...
10.
Gomez-Chou S, Swidnicka-Siergiejko A, Badi N, Chavez-Tomar M, Lesinski G, Bekaii-Saab T, et al.
Cancer Res
. 2017 Mar;
77(10):2647-2660.
PMID: 28249896
Lipocalin-2 (LCN2) promotes malignant development in many cancer types. LCN2 is upregulated in patients with pancreatic ductal adenocarcinoma (PDAC) and in obese individuals, but whether it contributes to PDAC development...